Cargando…

Off‐target ACE2 ligands: Possible therapeutic option for CoVid‐19?

Detalles Bibliográficos
Autores principales: Brogi, Simone, Calderone, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256127/
https://www.ncbi.nlm.nih.gov/pubmed/32359080
http://dx.doi.org/10.1111/bcp.14343
_version_ 1783539851198464000
author Brogi, Simone
Calderone, Vincenzo
author_facet Brogi, Simone
Calderone, Vincenzo
author_sort Brogi, Simone
collection PubMed
description
format Online
Article
Text
id pubmed-7256127
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-72561272020-06-03 Off‐target ACE2 ligands: Possible therapeutic option for CoVid‐19? Brogi, Simone Calderone, Vincenzo Br J Clin Pharmacol Letters to the Editor John Wiley and Sons Inc. 2020-05-13 2020-06 /pmc/articles/PMC7256127/ /pubmed/32359080 http://dx.doi.org/10.1111/bcp.14343 Text en © 2020 The British Pharmacological Society
spellingShingle Letters to the Editor
Brogi, Simone
Calderone, Vincenzo
Off‐target ACE2 ligands: Possible therapeutic option for CoVid‐19?
title Off‐target ACE2 ligands: Possible therapeutic option for CoVid‐19?
title_full Off‐target ACE2 ligands: Possible therapeutic option for CoVid‐19?
title_fullStr Off‐target ACE2 ligands: Possible therapeutic option for CoVid‐19?
title_full_unstemmed Off‐target ACE2 ligands: Possible therapeutic option for CoVid‐19?
title_short Off‐target ACE2 ligands: Possible therapeutic option for CoVid‐19?
title_sort off‐target ace2 ligands: possible therapeutic option for covid‐19?
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256127/
https://www.ncbi.nlm.nih.gov/pubmed/32359080
http://dx.doi.org/10.1111/bcp.14343
work_keys_str_mv AT brogisimone offtargetace2ligandspossibletherapeuticoptionforcovid19
AT calderonevincenzo offtargetace2ligandspossibletherapeuticoptionforcovid19